Delivery Order SPE2DB22D1052-SPE2DB25FU9US
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7ml units, with a ceiling value of $1,873.23. This non-competitive, firm fixed price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $1,328.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bromfenac Sodium 0.09% eye drops (1.7 mL) on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Bromfenac Sodium 0.09% eye drops (1.7 mL) with a ceiling value of $7,904.95. This firm fixed-price delivery order is non-competitive and represents a single pharmaceutical product delivery to support federal medical supply needs. The contract is set to reach ultimate completion by August 13, 2025, with performance conducted from the contractor's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7mL units, with a contract ceiling value of $9,699.75. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of May 21, 2025. The delivery order is a child contract issued under AmerisourceBergen's...
- This is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Bromfenac Sodium 0.09% eye drops. The contract is valued at $3,011.19 and has a firm fixed price pricing type. The ultimate completion date for this order is February 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% Eye Drops in 1.7 mL vials, with a ceiling value of $2,417.25 and a completion date of December 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,383.81 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bromfenac Sodium 0.09% eye drops. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Bromfenac Sodium 0.09% Eye Drops 1.7 mL. The contract has a firm-fixed price and a ceiling value of $1,860.93. It was awarded on August 7, 2024, with an ultimate completion date of August 8, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the provision of Bromfenac Sodium 0.09% Eye Drops in 1.7ml containers, with a total ceiling value of $1,131.37 and a period of performance through March 12, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Bromfenac Sodium 0.09% eye drops. This $1,488.72 contract has a performance period through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9USDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,139.92 to AmerisourceBergen Drug Corp for the supply of Bromfenac Sodium 0.09% eye drops (1.7mL units). This firm fixed-price delivery order, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive $999.99 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. The contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. AmerisourceBergen's extensive portfolio of federal medical procurement demonstrates its critical role as a major pharmaceutical distributor supporting military and veteran healthcare needs through competitively awarded contracts with consistent firm fixed pricing models.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 8/8/25 |